{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:21:53Z","timestamp":1783146113935,"version":"3.54.6"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Foundation Project of Guangxi","award":["2025GXNSFAA069067"],"award-info":[{"award-number":["2025GXNSFAA069067"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260558"],"award-info":[{"award-number":["82260558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01404-1","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:11:34Z","timestamp":1783145494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MiR-7-5p suppresses TGF-\u03b2-induced glycolysis and proliferation in intrahepatic cholangiocarcinoma by targeting MyD88"],"prefix":"10.1007","volume":"39","author":[{"given":"Yi","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"key":"1404_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, et al. Cholangiocarcinoma. Nat Rev Dis Primers. 2021;7:65.","journal-title":"Nat Rev Dis Primers"},{"key":"1404_CR2","first-page":"198","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, et al. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin. 2023;73:198\u2013222.","journal-title":"CA Cancer J Clin"},{"key":"1404_CR3","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1245\/s10434-019-07176-3","volume":"26","author":"U Yanala","year":"2019","unstructured":"Yanala U, Malhotra G, Are C, Padussis J. Intrahepatic cholangiocarcinoma: rising burden and glaring disparities. Ann Surg Oncol. 2019;26:1979\u201380.","journal-title":"Ann Surg Oncol"},{"key":"1404_CR4","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2020","unstructured":"Rumgay H, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2020;77:1598\u2013606.","journal-title":"J Hepatol"},{"key":"1404_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jso.24093","volume":"113","author":"KA Simo","year":"2016","unstructured":"Simo KA, Halpin LE, McBrier NM, et al. Multimodality treatment of intrahepatic cholangiocarcinoma: a review. J Surg Oncol. 2016;113:62\u201383.","journal-title":"J Surg Oncol"},{"key":"1404_CR6","doi-asserted-by":"publisher","first-page":"2310196","DOI":"10.1080\/07853890.2024.2310196","volume":"56","author":"Y Li","year":"2024","unstructured":"Li Y, Yu J, Zhang Y, et al. Advances in targeted therapy of cholangiocarcinoma. Ann Med. 2024;56:2310196.","journal-title":"Ann Med"},{"key":"1404_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147627","volume":"22","author":"T Shi","year":"2021","unstructured":"Shi T, Morishita A, Kobara H, Masaki T. The role of microRNAs in cholangiocarcinoma. Int J Mol Sci. 2021;22:7627.","journal-title":"Int J Mol Sci"},{"key":"1404_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ncrna.2023.11.003","volume":"9","author":"Z Wu","year":"2024","unstructured":"Wu Z, Jiang S, Chen Y. Non-coding RNA and Drug resistance in cholangiocarcinoma. Non-coding RNA Res. 2024;9:194\u2013202.","journal-title":"Non-coding RNA Res"},{"key":"1404_CR9","first-page":"809","volume":"9","author":"Y Tang","year":"2021","unstructured":"Tang Y, Tang Z, Yang J, Liu T, Tang Y. MicroRNA-7-5p inhibits migration, invasion and metastasis of intrahepatic cholangiocarcinoma by inhibiting MyD88. J Clin Transl Hepatol. 2021;9:809\u201317.","journal-title":"J Clin Transl Hepatol"},{"key":"1404_CR10","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/cells8090960","volume":"8","author":"P Papoutsoglou","year":"2019","unstructured":"Papoutsoglou P, Louis C, Coulouarn C. Transforming Growth Factor-Beta (TGF\u03b2) signaling pathway in cholangiocarcinoma. Cells. 2019;8:960.","journal-title":"Cells"},{"key":"1404_CR11","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.3390\/biomedicines13092214","volume":"13","author":"Y Yang","year":"2025","unstructured":"Yang Y, Li Z, Zhao M, et al. Attenuation of pulmonary fibrosis by the MyD88 inhibitor TJ-M2010-5 through autophagy induction in mice. Biomedicines. 2025;13:2214.","journal-title":"Biomedicines"},{"key":"1404_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41419-022-04802-z","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Liu Y, Chen H, et al. MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization. Cell Death Dis. 2022;13:411.","journal-title":"Cell Death Dis"},{"key":"1404_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70733","volume":"29","author":"K Lin","year":"2025","unstructured":"Lin K, Yang N, Hu C, et al. Myeloid MyD88 mediates macrophage infiltration and activation in Ang II-induced cardiac hypertrophy. J Cell Mol Med. 2025;29:e70733.","journal-title":"J Cell Mol Med"},{"key":"1404_CR14","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00018-019-03398-6","volume":"77","author":"W Hua","year":"2020","unstructured":"Hua W, Ten Dijke P, Kostidis S, Giera M, Hornsveld M. TGF\u03b2-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer. Cell Mol Life Sci. 2020;77:2103\u201323.","journal-title":"Cell Mol Life Sci"},{"key":"1404_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102035","volume":"47","author":"F Liu","year":"2024","unstructured":"Liu F, Wang Q, Wang Z, et al. ETV4 promotes the progression of cholangiocarcinoma by regulating glycolysis via the TGF-\u03b2 signaling. Transl Oncol. 2024;47:102035.","journal-title":"Transl Oncol"},{"key":"1404_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000204","volume":"7","author":"Z Tang","year":"2023","unstructured":"Tang Z, Yang Y, Chen W, Liang T. Epigenetic deregulation of MLF1 drives intrahepatic cholangiocarcinoma progression through EGFR\/AKT and Wnt\/\u03b2-catenin signaling. Hepatol Commun. 2023;7:e0204.","journal-title":"Hepatol Commun"},{"key":"1404_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100737","volume":"27","author":"A Elvevi","year":"2022","unstructured":"Elvevi A, Laffusa A, Scaravaglio M, et al. Clinical treatment of cholangiocarcinoma: an updated comprehensive review. Ann Hepatol. 2022;27:100737.","journal-title":"Ann Hepatol"},{"key":"1404_CR18","doi-asserted-by":"publisher","first-page":"1142690","DOI":"10.3389\/fimmu.2023.1142690","volume":"14","author":"J Du","year":"2023","unstructured":"Du J, Lv X, Zhang Z, Huang Z, Zhang E. Revisiting targeted therapy and immunotherapy for advanced cholangiocarcinoma. Front Immunol. 2023;14:1142690.","journal-title":"Front Immunol"},{"key":"1404_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13045-025-01716-z","volume":"18","author":"C Liu","year":"2025","unstructured":"Liu C, Wang X, Liu E, et al. Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution. J Hematol Oncol. 2025;18:66.","journal-title":"J Hematol Oncol"},{"key":"1404_CR20","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/jnci\/djt120","volume":"105","author":"A Kfoury","year":"2013","unstructured":"Kfoury A, Le Corf K, El Sabeh R, et al. MyD88 in DNA repair and cancer cell resistance to genotoxic drugs. J Natl Cancer Inst. 2013;105:937\u201346.","journal-title":"J Natl Cancer Inst"},{"key":"1404_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/IAE.0000000000000921","volume":"36","author":"JS Pulido","year":"2016","unstructured":"Pulido JS, Raja H, Vile RG, Salomao DR, Viswanatha DS. Mighty MyD88 in health and disease. Retina. 2016;36:429\u201331.","journal-title":"Retina"},{"key":"1404_CR22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/biom14050562","volume":"14","author":"J Song","year":"2024","unstructured":"Song J, Li Y, Wu K, Hu Y, Fang L. MyD88 and its inhibitors in cancer: prospects and challenges. Biomolecules. 2024;14:562.","journal-title":"Biomolecules"},{"key":"1404_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3892\/mmr.2021.11869","volume":"23","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wan Y, Feng J, Li M, Jiang Z. Involvement of TLR2\/4-MyD88-NF-\u03baB signaling pathway in the pathogenesis of intracranial aneurysm. Mol Med Rep. 2021;23:230.","journal-title":"Mol Med Rep"},{"key":"1404_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3892\/or.2023.8585","volume":"50","author":"S Lu","year":"2023","unstructured":"Lu S, He T, Zhang Y, et al. The MyD88 inhibitor, ST2825, induces cell cycle arrest and apoptosis by suppressing the activation of the NF-\u03baB\/AKT1\/p21 pathway in pancreatic cancer. Oncol Rep. 2023;50:148.","journal-title":"Oncol Rep"},{"key":"1404_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.21873\/cgp.20145","volume":"16","author":"G Zhu","year":"2019","unstructured":"Zhu G, Cheng Z, Lin C, et al. MyD88 Regulates LPS-induced NF-\u0138B\/MAPK Cytokines and Promotes Inflammation and Malignancy in Colorectal Cancer Cells. Cancer Genomics Proteomics. 2019;16:409\u201319.","journal-title":"Cancer Genomics Proteomics"},{"key":"1404_CR26","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1007\/s10753-023-01877-4","volume":"46","author":"H Fan","year":"2023","unstructured":"Fan H, Wang Y, Zhao K, et al. Incomplete Knockdown of MyD88 Inhibits LPS-Induced Lung Injury and Lung Fibrosis in a Mouse Model. Inflammation. 2023;46:2276\u201388.","journal-title":"Inflammation"},{"key":"1404_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.ade0385","volume":"16","author":"T Gauthier","year":"2023","unstructured":"Gauthier T, Yao C, Dowdy T, et al. TGF-\u03b2 uncouples glycolysis and inflammation in macrophages and controls survival during sepsis. Sci Signal. 2023;16:eade0385.","journal-title":"Sci Signal"},{"key":"1404_CR28","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/path.5856","volume":"256","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Zhang J, Liu Y, et al. MyD88 in myofibroblasts regulates aerobic glycolysis-driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation. J Pathol. 2022;256:414\u201326.","journal-title":"J Pathol"},{"key":"1404_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11033-024-10107-5","volume":"52","author":"Z Mirzaei","year":"2024","unstructured":"Mirzaei Z, Barati T, Ebrahimi A, Derakhshan SM, Khaniani MS. The role of mir-7-5p in cancer: function, prognosis, diagnosis, and therapeutic implications. Mol Biol Rep. 2024;52:12.","journal-title":"Mol Biol Rep"},{"key":"1404_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ncrna.2020.11.003","volume":"5","author":"SY Woo","year":"2020","unstructured":"Woo SY, Lee SY, Yu SL, et al. MicroRNA-7-5p\u2019s role in the O-GlcNAcylation and cancer metabolism. Noncoding RNA Res. 2020;5:201\u20137.","journal-title":"Noncoding RNA Res"},{"key":"1404_CR31","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.drudis.2020.11.017","volume":"26","author":"I Alroy","year":"2021","unstructured":"Alroy I, Mansour W, Klepfish M, Sheinberger Y. Expanding small-molecule target space to mRNA translation regulation. Drug Discov Today. 2021;26:786\u201393.","journal-title":"Drug Discov Today"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01404-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01404-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01404-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:11:36Z","timestamp":1783145496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01404-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1404"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01404-1","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"15 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were approved by the People\u2019s Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, (Ethics No. KY-KJT-2024\u201332), which were performed in accordance with ARRIVE guidelines, and approved by the laboratory animal ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"98"}}